- Represented Taishan Gypsum Co. Ltd.in a high-profile Chinese drywall product liability litigation pending before the Eastern District of Louisiana as a multidistrict litigation seeking class wide damages.
- Represented one of the world’s largest telecom carriers in multiple merits hearings where client received full defense verdicts and attorneys’ fees.
- Represented a major pharmaceutical company in a billion-dollar ICC arbitration regarding breach of a collaboration agreement and obtained favorable results for the client.
- Represented both plaintiffs and defendants in commercial arbitrations involving business-to-business disputes ranging from breach of vendor agreements to fraud.
- Trial counsel for a major U.S. commercial bank in a merits hearing where the client received a strong defense verdict and a counterclaim damages award.
- Represented a luxury car manufacturer in class action litigation alleging product defect, which was settled on very favorable terms prior to class certification briefing.
- Represented a leading technology company in the prosecution of antitrust claims over price fixing by lithium-ion battery suppliers.
- Represented a Fortune 500 company against antitrust claims in the ITC alleging price fixing, group boycott, and monopolization in the first antitrust case ever instituted in the ITC.
- Represented a major pharmaceutical company in the prosecution of federal antitrust action seeking damages under Sections 1 and 2 of the Sherman Act.
- Represented a major pharmaceutical company in litigation alleging price fixing and other antitrust claims.
Partner,
- Phone: +1 404 881 4650
- Email: matt.lawson@alston.com
Matt's background as a criminal defense investigator and experience conducting witness interviews helps him to identify and address the key weaknesses in a client's defense strategy and to make sure that the right issues are addressed in depositions to minimize the chances of a surprise at trial.
Matt Lawson is a partner in the firm’s Litigation & Trial Practice Group. Matt has a decade of experience representing companies in complex commercial litigation matters including high-stakes class action and multidistrict litigation in the areas of products liability, antitrust, and mass torts. He has experience at all stages of bet-the-company complex disputes, including trial experience, and has represented clients in a variety of industries, including technology, telecommunications, construction, pharmaceutical, and manufacturing. Matt was recognized in the 2025 Best Lawyers – Ones to Watch® for Mass Tort Litigation/ Class Action Defendants.
Before law school, Matt worked for three years as a criminal defense investigator in Washington D.C., primarily conducting witness interviews. Matt received his J.D., cum laude, from the University of Michigan Law School. He received his B.A. in political science and U.S. history from the University of Michigan.
-
Class Action MDL Roundup March 26, 2025Class Action & MDL Roundup 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup March 26, 2025Class Action & MDL Roundup 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup January 3, 2025Class Action & MDL Roundup 2024 Q3 – Our market research is sustainableIn this edition, it’s not a breach if it isn’t stolen, a greenwashing claim is washed away, and a district court’s denial swims with the fishes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup January 3, 2025Class Action & MDL Roundup 2024 Q3 – Our market research is sustainableIn this edition, it’s not a breach if it isn’t stolen, a greenwashing claim is washed away, and a district court’s denial swims with the fishes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup March 21, 2024Class Action & MDL Roundup 2023 Q4 - Not all cases survive and advance
In this edition, student-athletes win an NIL round, Canadians in California isn’t personal (jurisdiction), and it’s only a duty to disclose when it’s material. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Class Action MDL Roundup March 21, 2024Class Action & MDL Roundup 2023 Q4 - Not all cases survive and advanceIn this edition, student-athletes win an NIL round, Canadians in California isn’t personal (jurisdiction), and it’s only a duty to disclose when it’s material. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
In the News January 4, 2024Daily Report | Alston and Kilpatrick Keep Up Atlanta-Heavy Partner PromotionsNewly elected partners Robert Ardern, Elizabeth Buckel, Michael Deane, Chad Fights, Tim Fitzmaurice, Anna French, Meredith Gage, John Gerl, Kerri-Ann Griggs, William Hao, Andrew Hatchett, Sam Jockel, Jacob Johnson, Matthew Johnson, Matthew Lawson, Andrew Liebler, Antone Little, Bhanu Mathur, Tyler Pate, Alan Pryor, Courtney Quirós, Daniel Rowe, Joanna Schorr, Chris Underwood, Emily Welch, and Seaira Wolf are mentioned.In the News January 4, 2024Daily Report | Alston and Kilpatrick Keep Up Atlanta-Heavy Partner PromotionsNewly elected partners Robert Ardern, Elizabeth Buckel, Michael Deane, Chad Fights, Tim Fitzmaurice, Anna French, Meredith Gage, John Gerl, Kerri-Ann Griggs, William Hao, Andrew Hatchett, Sam Jockel, Jacob Johnson, Matthew Johnson, Matthew Lawson, Andrew Liebler, Antone Little, Bhanu Mathur, Tyler Pate, Alan Pryor, Courtney Quirós, Daniel Rowe, Joanna Schorr, Chris Underwood, Emily Welch, and Seaira Wolf are mentioned.
-
In the News January 4, 2024Law360 | Litigators Dominate in Alston & Bird’s 27-Partner ClassNewly elected partners Robert Ardern, Elizabeth Buckel, Michael Deane, Chad Fights, Tim Fitzmaurice, Anna French, Meredith Gage, John Gerl, Kerri-Ann Griggs, William Hao, Andrew Hatchett, Sam Jockel, Jacob Johnson, Matthew Johnson, Matthew Lawson, Andrew Liebler, Antone Little, Bhanu Mathur, Tyler Pate, Alan Pryor, Courtney Quirós, Daniel Rowe, Joanna Schorr, Chris Underwood, Emily Welch, and Seaira Wolf are mentioned.In the News January 4, 2024Law360 | Litigators Dominate in Alston & Bird’s 27-Partner ClassNewly elected partners Robert Ardern, Elizabeth Buckel, Michael Deane, Chad Fights, Tim Fitzmaurice, Anna French, Meredith Gage, John Gerl, Kerri-Ann Griggs, William Hao, Andrew Hatchett, Sam Jockel, Jacob Johnson, Matthew Johnson, Matthew Lawson, Andrew Liebler, Antone Little, Bhanu Mathur, Tyler Pate, Alan Pryor, Courtney Quirós, Daniel Rowe, Joanna Schorr, Chris Underwood, Emily Welch, and Seaira Wolf are mentioned.
-
Press Release January 3, 2024Alston & Bird Elects 27 New PartnersAlston & Bird announces the election of 27 lawyers to its partnership, effective January 1, 2024. The new partners span six offices and 11 practice groups.Press Release January 3, 2024Alston & Bird Elects 27 New PartnersAlston & Bird announces the election of 27 lawyers to its partnership, effective January 1, 2024. The new partners span six offices and 11 practice groups.
-
Class Action MDL Roundup December 18, 2023Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2023, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup December 18, 2023Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2023, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.Class Action MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Bar Admissions
- Georgia
Education
- University of Michigan (J.D., 2013)
- University of Michigan (B.A., 2007)